End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.09 CNY | -0.07% | -4.55% | -11.34% |
Business Summary
Number of employees: 9,223
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Chinese Medicines
68.8
%
| 5,557 | 64.7 % | 5,971 | 68.8 % | +7.46% |
Pharmaceutical Business
14.0
%
| 1,417 | 16.5 % | 1,215 | 14.0 % | -14.21% |
Chemical Pharmaceuticals
13.9
%
| 1,270 | 14.8 % | 1,203 | 13.9 % | -5.30% |
Biological Drugs
2.2
%
| 248 | 2.9 % | 190 | 2.2 % | -23.47% |
Chemical Raw Materials
0.7
%
| 71 | 0.8 % | 57 | 0.7 % | -19.67% |
Other Business
0.4
%
| 31 | 0.4 % | 38 | 0.4 % | +22.38% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
99.7
%
| 8,593 | 100.0 % | 8,635 | 99.7 % | +0.49% |
Overseas
0.3
%
| - | - | 23 | 0.3 % | - |
Managers
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Xiao Meng Jiang
BRD | Director/Board Member | 60 | 07-08-16 |
Nai Feng Wu
BRD | Director/Board Member | 72 | 05-09-08 |
Kai Jing Yan
CHM | Chairman | 45 | 14-03-27 |
He Sun
BRD | Director/Board Member | 65 | 15-04-26 |
Zheng Liang Ye
CHM | Chairman | 57 | 18-04-15 |
Ai Chun Ju
BRD | Director/Board Member | 51 | 14-04-13 |
Jing Su
CEO | Chief Executive Officer | 61 | 18-04-15 |
Liu Xin
BRD | Director/Board Member | 56 | 18-04-15 |
Bin Zhang
BRD | Director/Board Member | 70 | 21-06-01 |
Shunnan Zhang
BRD | Director/Board Member | 51 | 18-04-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,493,950,005 | 736,727,818 ( 49.31 %) | 0 | 49.31 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
IMMUNOTECH BIOPHARM LTD 18.87% | 97,102,571 | 18.87% | 40,846,196 $ |
Company contact information
Tasly Pharmaceutical Group Co., Ltd.
2, Puji River East Road Beichen District
300410, Tianjin
+86 22 2673 6999
http://www.tasly.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.34% | 3.12B | |
+41.06% | 6.26B | |
-15.95% | 4.49B | |
+6.36% | 3.29B | |
-3.12% | 2.5B | |
+45.41% | 1.94B | |
-7.74% | 1.68B | |
-0.67% | 1.63B | |
-11.32% | 1.56B | |
+49.16% | 1.52B |
- Stock Market
- Equities
- 600535 Stock
- Company Tasly Pharmaceutical Group Co., Ltd